U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C2H2N2O
Molecular Weight 70.0501
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 1,3,4-OXADIAZOLE

SMILES

O1C=NN=C1

InChI

InChIKey=FKASFBLJDCHBNZ-UHFFFAOYSA-N
InChI=1S/C2H2N2O/c1-3-4-2-5-1/h1-2H

HIDE SMILES / InChI

Molecular Formula C2H2N2O
Molecular Weight 70.0501
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

PubMed

PubMed

TitleDatePubMed
Allosteric regulation of glycogen synthase kinase 3β: a theoretical study.
2010-12-28
Bromidotricarbon-yl[2-phenyl-5-(pyridin-2-yl-κN)-1,3,4-oxadiazole-κN]rhenium(I) dichloro-methane monosolvate.
2010-12-18
A two-photon excited luminescence of water-soluble rhodamine-platinum(II) complex: fluorescent probe specific for Hg2+ detection in live cell.
2010-12-15
Bromidotricarbon-yl[2-(pyridin-2-yl-κN)-5-p-tolyl-1,3,4-oxadiazole-κN]rhenium(I) dichloro-methane monosolvate.
2010-12-04
Synthesis, biological evaluation, and molecular docking studies of 2-chloropyridine derivatives possessing 1,3,4-oxadiazole moiety as potential antitumor agents.
2010-11-15
Synthesis and biological evaluation of some 1,3,4-oxadiazole derivatives.
2010-11
Design, synthesis and biological evaluation of 1,3,4-oxadiazole derivatives.
2010-11
Synthesis and pharmacological evaluation of condensed heterocyclic 6-substituted 1,2,4-triazolo-[3,4-b]-1,3,4-thiadiazole and 1,3,4-oxadiazole derivatives of isoniazid.
2010-08-15
New hyperbranched conjugated polymers containing hexaphenylbenzene and oxadiazole units: convenient synthesis and efficient deep blue emitters for PLEDs application.
2010-07-22
Efficient Electrochemical Synthesis, Antimicrobial and Antiinflammatory Activity of 2-amino-5-substituted- 1,3,4-oxadiazole Derivatives.
2010-07
QSAR study of substituted 1,3,4-oxadiazole naphthyridines as HIV-1 integrase inhibitors.
2010-07
A practical synthesis of 5-lipoxygenase inhibitor MK-0633.
2010-06-18
Novel one-pot, four-component condensation reaction: an efficient approach for the synthesis of 2,5-disubstituted 1,3,4-oxadiazole derivatives by a Ugi-4CR/aza-Wittig sequence.
2010-06-18
Synthesis of novel 1,3,4-oxadiazole derivatives as potential antimicrobial agents.
2010-06-08
Synthesis of a second generation chroman/catechol hybrids and evaluation of their activity in protecting neuronal cells from oxidative stress-induced cell death.
2010-06-01
4-Chloro-N-[3-methyl-1-(5-thioxo-4,5-dihydro-1,3,4-oxadiazol-2-yl)but-yl]benzamide.
2010-05-19
Molecular logic gates and switches based on 1,3,4-oxadiazoles triggered by metal ions.
2010-05-17
Synthesis of some novel 2-substituted-5-[isopropylthiazole] clubbed 1,2,4-triazole and 1,3,4-oxadiazoles as potential antimicrobial and antitubercular agents.
2010-05
Novel derivatives of 1,3,4-oxadiazoles are potent mitostatic agents featuring strong microtubule depolymerizing activity in the sea urchin embryo and cell culture assays.
2010-05
Synthesis and anti-inflammatory evaluation of some condensed [4-(3,4-dimethylphenyl)-1(2H)-oxo-phthalazin-2-yl]acetic acid hydrazide.
2010-04
Asymmetric total synthesis of vindoline.
2010-03-24
Total synthesis of (+)-fendleridine (aspidoalbidine) and (+)-1-acetylaspidoalbidine.
2010-03-10
Synthesis, characterization and biological activity of some new 1,3,4-oxadiazole bearing 2-flouro-4-methoxy phenyl moiety.
2010-03
Anti-HIV activity of new substituted 1,3,4-oxadiazole derivatives and their acyclic nucleoside analogues.
2010-02-18
A possible correlation between the correction of endothelial dysfunction and normalization of high blood pressure levels by 1,3,4-oxadiazole derivative, an L-type Ca2+ channel blocker in deoxycorticosterone acetate and N(G)-nitro-l-arginine hypertensive rats.
2010-01-27
Synthesis and characterization of organic dyes containing various donors and acceptors.
2010-01-22
The modulation of electronic and optical properties of OXD-X through introduction of the electron-withdrawing groups: a DFT study.
2010-01
Synthesis and antimicrobial activity of 3-(1,3,4-Oxadiazol-2-yl)quinazolin-4(3H)-ones.
2009-12-17
2-(4-tert-Butyl-phen-yl)-5-p-tolyl-1,3,4-oxadiazole.
2009-12-04
Vasorelaxant effect in rat aortic rings through calcium channel blockage: a preliminary in vitro assessment of a 1,3,4-oxadiazole derivative.
2009-10-30
2-{3-[4-(Alkylsulfinyl)phenyl]-1-benzofuran-5-yl}-5-methyl-1,3,4-oxadiazole derivatives as novel inhibitors of glycogen synthase kinase-3beta with good brain permeability.
2009-10-22
Design, synthesis and hypolipidemic activity of novel 2-(naphthalen-2-yloxy)propionic acid derivatives as desmethyl fibrate analogs.
2009-10
Synthesis and pharmacological evaluation of 1,3,4-oxadiazole bearing bis(heterocycle) derivatives as anti-inflammatory and analgesic agents.
2009-10
Design and synthesis of novel neuroprotective 1,2-dithiolane/chroman hybrids.
2009-09-01
5-[1-(3,4-Dichloro-phen-oxy)eth-yl]-1,3,4-oxadiazole-2(3H)-thione hemihydrate.
2009-08-08
Methylsulfonylpyrazolyl oxadiazoles and thiadiazoles as potent, orally bioavailable cannabinoid-1 receptor antagonists for the treatment of obesity.
2009-08
A new type of five-membered heterocyclic inhibitors of basic metallocarboxypeptidases.
2009-08
Synthesis of novel 1,3,4-oxadiazole derivatives and their biological properties.
2009-06
(2S)-Methyl 2-(4-chloro-benzene-sulfon-amido)-4-(methyl-sulfan-yl)butanoate.
2009-05-20
(2S)-Methyl 2-(p-toluenesulfonamido)propanoate.
2009-05-14
Luminescent, liquid crystalline tris(N-salicylideneaniline)s: synthesis and characterization.
2009-04-17
Raltegravir, elvitegravir, and metoogravir: the birth of "me-too" HIV-1 integrase inhibitors.
2009-03-05
N,N'-Diacetyl-N'-[(4-nitro-phen-oxy)acetyl]acetohydrazide.
2009-01-23
Synthesis and Biological Evaluation of beta-Aroylpropionic acid based 1,3,4-Oxadiazoles.
2009-01
N,N'-Dibenzyl-2,2'-[(1,3,4-oxadiazole-2,5-di-yl)bis-(o-phenyl-eneoxy)]diacet-amide.
2008-10-31
1-[2-(3,4-Dichloro-phen-yl)-5-(3,4,5-trimethoxy-phen-yl)-2,3-dihydro-1,3,4-oxadiazol-3-yl]ethanone.
2008-07-09
Ethyl 2-(5-phenyl-1,3,4-oxadiazol-2-ylsulfan-yl)acetate.
2008-03-20
N,N-Dimethyl-4-[5-(5-methyl-1-phenyl-1H-pyrazol-4-yl)-1,3,4-oxadiazol-2-yl]aniline.
2008-01-04
Synthesis, Antimicrobial and Antiinflammatory Activity of 2,5-Disubstituted-1,3,4-oxadiazoles.
2008-01
N-Phenyl-N-{4-[5-(4-pyrid-yl)-1,3,4-oxadiazol-2-yl]phen-yl}aniline.
2007-12-12
Patents

Patents

Substance Class Chemical
Created
by admin
on Mon Mar 31 21:19:17 GMT 2025
Edited
by admin
on Mon Mar 31 21:19:17 GMT 2025
Record UNII
20O2F20OUR
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
NSC-122449
Preferred Name English
1,3,4-OXADIAZOLE
MI  
Systematic Name English
1,3,4-OXADIAZOLE [MI]
Common Name English
1-OXA-3,4-DIAZACYCLOPENTADIENE
Systematic Name English
Code System Code Type Description
WIKIPEDIA
1,3,4-Oxadiazole
Created by admin on Mon Mar 31 21:19:17 GMT 2025 , Edited by admin on Mon Mar 31 21:19:17 GMT 2025
PRIMARY
CHEBI
46810
Created by admin on Mon Mar 31 21:19:17 GMT 2025 , Edited by admin on Mon Mar 31 21:19:17 GMT 2025
PRIMARY
NSC
122449
Created by admin on Mon Mar 31 21:19:17 GMT 2025 , Edited by admin on Mon Mar 31 21:19:17 GMT 2025
PRIMARY
FDA UNII
20O2F20OUR
Created by admin on Mon Mar 31 21:19:17 GMT 2025 , Edited by admin on Mon Mar 31 21:19:17 GMT 2025
PRIMARY
MERCK INDEX
m8275
Created by admin on Mon Mar 31 21:19:17 GMT 2025 , Edited by admin on Mon Mar 31 21:19:17 GMT 2025
PRIMARY Merck Index
EPA CompTox
DTXSID10182987
Created by admin on Mon Mar 31 21:19:17 GMT 2025 , Edited by admin on Mon Mar 31 21:19:17 GMT 2025
PRIMARY
CAS
288-99-3
Created by admin on Mon Mar 31 21:19:17 GMT 2025 , Edited by admin on Mon Mar 31 21:19:17 GMT 2025
PRIMARY
PUBCHEM
97428
Created by admin on Mon Mar 31 21:19:17 GMT 2025 , Edited by admin on Mon Mar 31 21:19:17 GMT 2025
PRIMARY